Latest News

Ceapro announces a $1.6 million grant from Alberta Innovates Bio Solutions

EDMONTON, ALBERTA – February 27, 2012 – Ceapro Inc. (CZO–V) (“Ceapro” or the Company”) is very pleased to announce the execution of an agreement with Alberta Innovates Bio Solutions who has awarded the Company a $1.6 million grant to establish a state of the art commercial scale

Read more

Ceapro Defends Additional Claim from AVAC Ltd.

Edmonton, Alberta –February 10, 2012 – Ceapro Inc. (CZO – TSX Venture) (“Ceapro” or the “Company”) announced today it and its wholly owned subsidiary, Ceapro Technology Inc. (“CTI”), were served with a Statement of Claim filed in the Court of Queens Bench of Alberta by AVAC Ltd.

Read more

Ceapro Retains Renmark Financial Communications Inc.

EDMONTON, ALBERTA, Canada —February 3, 2012 — Ceapro Inc. (TSX-V CZO) is pleased to announce that it has retained the services of Renmark Financial Communications Inc. to handle its investor relations activities. “We are pleased to announce that we have selected Renmark to reinforce Ceapro’s profile in

Read more

Ceapro Announces $370,000 of Convertible Debentures Converted to Equity

EDMONTON, ALBERTA, Canada —January 3, 2012 — Ceapro Inc. (TSX-V CZO) today announced that holders of $370,000 of the convertible debentures due December 31, 2011 have elected to convert their debentures into common shares at a conversion price of 10 cents per common share. This will result

Read more

Ceapro provides Update to Shareholders

Edmonton, AB–(Marketwire – December 6, 2011) – The following is a letter to shareholders from Ceapro Inc. Dear Shareholders: At Ceapro (TSXV: CZO) we are very pleased with our year to date 2011 financial results showing profitability and continuous improvement in our balance sheet. Significantly these results

Read more

Ceapro Reports Third Quarter 2011 Financial Results

EDMONTON, ALBERTA –November 29, 2011 – Ceapro Inc. (CZO TSX–V) (“Ceapro” or the Company”) today announced its financial results for the three-month and nine-month periods ended September 30, 2011. These results are presented in accordance with the International Financial Reporting Standards (IFRS) of the International Accounting Standards

Read more

Ceapro Announces Signing of a Sales Agreement With Ross Organic Specialty Sales Inc. for its certified All-Natural Active Ingredients in the Western United States

EDMONTON, ALBERTA–(Marketwire – October 12, 2011) – Ceapro Inc. (TSX VENTURE:CZO) (“Ceapro” or “the Company”) is pleased to announce today the signing of a new sales agreement with California based company, Ross Organic Specialty Sales Inc. The agreement encompasses Ceapro’s entire range of Ecocert™ certified all-natural active

Read more

Ceapro Files Statement of Defence

Edmonton, Alberta –September 29, 2011 – Ceapro Inc. (CZO – TSX Venture) (“Ceapro” or the Company”) announced today it and its wholly owned subsidiary, Ceapro Veterinary Products Inc., have filed a Statement of Defence in the Court of Queens Bench of Alberta to defend claims made by

Read more

Ceapro Defends Claim from AVAC Ltd.

Edmonton, Alberta –September 13, 2011 – Ceapro Inc. (CZO – TSX Venture) (“Ceapro” or the Company”) announced today it and its wholly owned subsidiary, Ceapro Veterinary Products Inc., were served with a Statement of Claim filed in the Court of Queens Bench of Alberta by AVAC Ltd.

Read more

Ceapro Reports Second Quarter 2011 Financial Results

EDMONTON, ALBERTA–(Marketwire – Aug. 10, 2011) – Ceapro Inc. (TSX VENTURE:CZO)(“Ceapro” or the Company”) today announced its financial results as at and for the three-month and the six-month periods ended June 30, 2011. These results are presented in accordance with the International Financial Reporting Standards (IFRS) of

Read more
Page 11 of 12« First...89101112